10 Individual results vary based on starting weight, dose, diet, and activity level
Tirzepatide functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Combination: Zepbound must also be used in combination with a reduced-calorie diet and increased physical activity
42%) Why it matters: For patients who dont want weekly injections, this oral GLP-1 could be a game-changerpotent, convenient, and expanding treatment choices
We understand that reducing food consumption can be challenging
By using GLP-1 agonists to remove this "regular" fat, we can: Decompress the Lymphatics: Less weight means less pressure on your lymphatic vessels, potentially improving flow and reducing swelling